Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-09 Purchase | 2023-03-13 07:59 am | ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director | 11,000 | $4.1953 | $46,148 | 20,101 (Indirect Direct) | View |
| 2022-05-18 Purchase | 2022-05-18 7:01 pm | KEMPHARM INC | KMPH | Plooster Matthew R Director | 5,000 | $4.9561 | $24,780 | 9,101 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-25 Option Award | 2023-05-08 9:53 pm | N/A 2033-04-24 | ZEVRA THERAPEUTICS INC. | ZVRA | Plooster Matthew R Director | 49,200 | $0 | 49,200 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 5:19 pm | N/A 2032-06-27 | KEMPHARM INC | KMPH | Plooster Matthew R Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-12-01 Option Award | 2021-12-01 4:28 pm | N/A N/A | KEMPHARM INC | KMPH | Plooster Matthew R Director | 2,500 | $8.44 | 4,101 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:35 am | N/A 2031-06-16 | KEMPHARM INC | KMPH | Plooster Matthew R Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-22 8:43 pm | N/A 2030-06-18 | KEMPHARM INC | KMPH | Plooster Matthew R Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2019-06-30 Option Award | 2019-07-02 5:03 pm | N/A N/A | KEMPHARM INC | KMPH | Plooster Matthew R Director | 7,857 | $0 | 25,629 (Direct) | View |
| 2019-05-10 Option Award | 2019-05-14 8:38 pm | N/A N/A | KEMPHARM INC | KMPH | Plooster Matthew R Director | 8,487 | $0 | 17,772 (Direct) | View |